Global Parkinson's Disease Treatment Market Research Report 2018 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition and Specification
• 1.2 Report Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
  • 1.2.3 Type Overview
  • 1.2.4 Application Overview
• 1.3 Industrial Chain
  • 1.3.1 Parkinson's Disease Treatment Overall Industrial Chain
  • 1.3.2 Upstream
  • 1.3.3 Downstream
• 1.4 Industry Situation
  • 1.4.1 Industrial Policy
  • 1.4.2 Product Preference
  • 1.4.3 Economic/Political Environment
• 1.5 SWOT Analysis

2 Market Analysis by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China Parkinson's Disease Treatment Market Performance
• 2.3 USA Parkinson's Disease Treatment Market Performance
• 2.4 Europe Parkinson's Disease Treatment Market Performance
• 2.5 Japan Parkinson's Disease Treatment Market Performance
• 2.6 Korea Parkinson's Disease Treatment Market Performance
• 2.7 India Parkinson's Disease Treatment Market Performance
• 2.8 Southeast Asia Parkinson's Disease Treatment Market Performance
• 2.9 South America Parkinson's Disease Treatment Market Performance

3 Product Application Market

• 3.1 Overall Market Performance (Volume)
• 3.2 China Parkinson's Disease Treatment Market Performance (Volume)
• 3.3 USA Parkinson's Disease Treatment Market Performance (Volume)
• 3.4 Europe Parkinson's Disease Treatment Market Performance (Volume)
• 3.5 Japan Parkinson's Disease Treatment Market Performance (Volume)
• 3.6 Korea Parkinson's Disease Treatment Market Performance (Volume)
• 3.7 India Parkinson's Disease Treatment Market Performance (Volume)
• 3.8 Southeast Asia Parkinson's Disease Treatment Market Performance (Volume)
• 3.9 South America Parkinson's Disease Treatment Market Performance (Volume)

4 Manufacturers Profiles/Analysis

• 4.1 Teva (Israel)
  • 4.1.1 Teva (Israel) Profiles
  • 4.1.2 Teva (Israel) Product Information
  • 4.1.3 Teva (Israel) Parkinson's Disease Treatment Business Performance
  • 4.1.4 Teva (Israel) Parkinson's Disease Treatment Business Development and Market Status
• 4.2 Novartis AG (Switzerland)
  • 4.2.1 Novartis AG (Switzerland) Profiles
  • 4.2.2 Novartis AG (Switzerland) Product Information
  • 4.2.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Business Performance
  • 4.2.4 Novartis AG (Switzerland) Parkinson's Disease Treatment Business Development and Market Status
• 4.3 GSK (UK)
  • 4.3.1 GSK (UK) Profiles
  • 4.3.2 GSK (UK) Product Information
  • 4.3.3 GSK (UK) Parkinson's Disease Treatment Business Performance
  • 4.3.4 GSK (UK) Parkinson's Disease Treatment Business Development and Market Status
• 4.4 AbbVie (US)
  • 4.4.1 AbbVie (US) Profiles
  • 4.4.2 AbbVie (US) Product Information
  • 4.4.3 AbbVie (US) Parkinson's Disease Treatment Business Performance
  • 4.4.4 AbbVie (US) Parkinson's Disease Treatment Business Development and Market Status
• 4.5 Merck (US)
  • 4.5.1 Merck (US) Profiles
  • 4.5.2 Merck (US) Product Information
  • 4.5.3 Merck (US) Parkinson's Disease Treatment Business Performance
  • 4.5.4 Merck (US) Parkinson's Disease Treatment Business Development and Market Status
• 4.6 Boehringer Ingelheim (Germany)
  • 4.6.1 Boehringer Ingelheim (Germany) Profiles
  • 4.6.2 Boehringer Ingelheim (Germany) Product Information
  • 4.6.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Performance
  • 4.6.4 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Business Development and Market Status
• 4.7 Impax Laboratories (US)
  • 4.7.1 Impax Laboratories (US) Profiles
  • 4.7.2 Impax Laboratories (US) Product Information
  • 4.7.3 Impax Laboratories (US) Parkinson's Disease Treatment Business Performance
  • 4.7.4 Impax Laboratories (US) Parkinson's Disease Treatment Business Development and Market Status
• 4.8 Lundbeck (Denmark)
  • 4.8.1 Lundbeck (Denmark) Profiles
  • 4.8.2 Lundbeck (Denmark) Product Information
  • 4.8.3 Lundbeck (Denmark) Parkinson's Disease Treatment Business Performance
  • 4.8.4 Lundbeck (Denmark) Parkinson's Disease Treatment Business Development and Market Status
• 4.9 UCB (Belgium)
  • 4.9.1 UCB (Belgium) Profiles
  • 4.9.2 UCB (Belgium) Product Information
  • 4.9.3 UCB (Belgium) Parkinson's Disease Treatment Business Performance
  • 4.9.4 UCB (Belgium) Parkinson's Disease Treatment Business Development and Market Status
• 4.10 Valeant Pharmaceuticals (Canada)
  • 4.10.1 Valeant Pharmaceuticals (Canada) Profiles
  • 4.10.2 Valeant Pharmaceuticals (Canada) Product Information
  • 4.10.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Performance
  • 4.10.4 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Business Development and Market Status
• 4.11 Acadia (US)
• 4.12 Sun Pharma (India)
• 4.13 GSK (UK)
• 4.14 AbbVie (US)
• 4.15 Merck (US)
• 4.20 Valeant Pharmaceuticals (Canada)

5 Market Performance for Manufacturers

• 5.1 Global Parkinson's Disease Treatment Production (K Units) and Market Share by Manufacturers 2013-2018
• 5.2 Global Parkinson's Disease Treatment Revenue (M USD) and Market Share by Manufacturers 2013-2018
• 5.3 Global Parkinson's Disease Treatment Price (USD/Unit) of Manufacturers 2013-2018
• 5.4 Global Parkinson's Disease Treatment Gross Margin of Manufacturers 2013-2018
• 5.5 Market Concentration

6 Global Parkinson's Disease Treatment Market Performance (Production Point)

• 6.1 Global Parkinson's Disease Treatment Production (K Units) and Market Share by Regions 2013-2018
• 6.2 Global Parkinson's Disease Treatment Revenue (M USD) and Market Share by Regions 2013-2018
• 6.3 Global Parkinson's Disease Treatment Price (USD/Unit) by Regions 2013-2018
• 6.4 Global Parkinson's Disease Treatment Gross Margin by Regions 2013-2018

7 Development Trend for Regions (Production Point)

• 7.1 Global Parkinson's Disease Treatment Production (K Units), Revenue (&$B$8&) and Growth Rate 2013-2018
• 7.2 China Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.3 USA Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.4 Europe Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.5 Japan Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.6 Korea Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.7 India Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.8 Southeast Asia Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018
• 7.9 South America Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2013-2018

8 Global Parkinson's Disease Treatment Market Performance (Consumption Point)

• 8.1 Global Parkinson's Disease Treatment Consumption and Market Share by Regions 2013-2018
• 8.2 Global Parkinson's Disease Treatment Consumption Value and Market Share by Regions 2013-2018
• 8.3 Global Parkinson's Disease Treatment Price (USD/Unit) by Regions 2013-2018

9 Development Trend for Regions (Sales Point)

• 9.1 Global Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.2 China Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.3 USA Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.4 Europe Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.5 Japan Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.6 Korea Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.7 India Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.8 Southeast Asia Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018
• 9.9 South America Parkinson's Disease Treatment Sales and Growth, Sales Value and Growth Rate2013-2018

10 Upstream Source, Technology and Cost

• 10.1 Upstream Source
• 10.2 Technology
• 10.3 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Consumer Analysis

• 12.1 Hospital Pharmacies Industry
• 12.2 Retailer Pharmacies Industry
• 12.3 Online Pharmacies Industry

13 Market Forecast 2019-2024

• 13.1 Production (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
  • 13.1.1 Global Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
  • 13.1.2 Global Parkinson's Disease Treatment Production (K Units) and Growth Rate 2019-2024
  • 13.1.3 China Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.4 USA Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.5 Europe Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.6 Japan Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.7 Korea Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.8 India Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.9 Southeast Asia Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.1.10 South America Parkinson's Disease Treatment Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.2 Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.1 Global Parkinson's Disease Treatment Consumption and Market Share by Regions 2019-2024
  • 13.2.2 Global Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.3 China Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.4 USA Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.5 Europe Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.6 Japan Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.7 Korea Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.8 India Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.9 Southeast Asia Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
  • 13.2.10 South America Parkinson's Disease Treatment Sales, Sales Value and Growth Rate 2019-2024
• 13.3 Production (K Units), Revenue (M USD) by Types 2019-2024
  • 13.3.1 Overall Market Performance
  • 13.3.2 Levodopa/carbidopa Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.3 Dopamine Receptor Agonists Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.4 MAO-Inhibitors Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
  • 13.3.5 COMT-inhibitors Production (K Units), Revenue (M USD) and Growth Rate 2019-2024
• 13.4 Sales by Application 2019-2024
  • 13.4.1 Overall Market Performance
  • 13.4.2 Hospital Pharmacies Sales and and Growth Rate 2019-2024
  • 13.4.3 Retailer Pharmacies Sales and and Growth Rate 2019-2024
  • 13.4.4 Online Pharmacies Sales and and Growth Rate 2019-2024
• 13.5 Price (USD/Unit) and Gross Profit
  • 13.5.1 Global Parkinson's Disease Treatment Price (USD/Unit) Trend 2019-2024
  • 13.5.2 Global Parkinson's Disease Treatment Gross Profit Trend 2019-2024

14 Conclusion